Technology
Health
Pharmaceutical

Kindred Biosciences

$6.33
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.45 (-6.64%) Today
$0.00 (0.00%) As of 4:27 PM EDT after-hours

Why Robinhood?

You can buy or sell KIN and other stocks, options, ETFs, and crypto commission-free!

About KIN

Kindred Biosciences, Inc. Common Stock, also called Kindred Biosciences, is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. Read More The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.

Employees
146
Headquarters
Burlingame, California
Founded
2012
Market Cap
263.93M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
200.42K
High Today
$6.81
Low Today
$6.31
Open Price
$6.78
Volume
438.69K
52 Week High
$15.75
52 Week Low
$6.31

Collections

Technology
Health
Pharmaceutical
Biopharmaceutical
Pets
2013 IPO
US
North America

KIN Earnings

-$0.46
-$0.41
-$0.35
-$0.30
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Aug 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.